(U.S., filed March 27, 2020): Urging the Court to review whether the chain of causation between a manufacturer’s allegedly false statements and end payments for prescription drugs is too attenuated to satisfy RICO’s proximate cause requirement. Also, to address whether everyone who pays for a product with an alleged latent risk or defect suffer injury sufficient to confer Article III standing.
The American Tort Reform Association (ATRA) is disappointed to learn that the U.S. Court of Appeals for the Third Circuit ruled against LTL Management, LLC in a case regarding the […]
This op-ed was originally published by Agri-Pulse. Mass tort litigation has become a multi-billion-dollar industry for trial lawyers over the past several decades as they’ve targeted everything from tobacco and […]
SB 2-A to improve FL property insurance; addresses assignment of benefits, one way attorney fee shifting, third-party bad faith
Arbitrary, excessive punishments result from lack of clarity under some laws
State ranked No. 3 among worst ‘Judicial Hellholes’ in nation with residents paying $1,900 per year in ‘tort tax’
Residents pay ‘tort tax’ of more than $1,010 amid all-time high inflation
